The report provides insights into GSK's tech activities, including its digital transformation strategies, its innovation programs, and its technology initiatives.Dublin, Feb. 06, 2025 (GLOBE NEWSWIRE) ...

GSK PLC (GSK) reports robust sales and profit growth, while navigating external pressures in the vaccine market and preparing for future product approvals.

January 2025 kicked off with a wave of impactful biotech deals, setting the stage for an exciting year of innovation.

Slaughter and May has elected David Johnson as its next managing partner, succeeding Deborah Finkler in the role. The change ...

Our immune system is armed with an array of defenses designed to detect and eliminate harmful threats. One of its most powerful defense mechanisms is ...

Innoviva, Inc. ("Innoviva" or the "Company"), a diversified holding company with a core royalties portfolio, a leading critical care and infectious disease platform known as Innoviva Specialty ...

While some of the initial zeal around localized vaccine production in Africa has waned since the height of the COVID-19 pandemic, efforts to bolster the continent’s immunization autonomy—especially | ...

UHAPO successfully organized the third edition of The Cancer Conclave 2025, a virtual gathering of leading oncologists, policymakers, researchers, NGOs, industry representatives, cancer survivors, and ...

Moderna stock tumbled after the Senate Finance Committee voted to send RFK Jr.'s nomination for the HHS secretary to the full ...

Slaughter and May has named a successor to managing partner Deborah Finkler. David Johnson is set to take the helm of the ...

If you suffered losses exceeding $75,000 in GSK between February 5, 2020 and August 14, 2022 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at ...